Cervical squamous cell carcinoma (CSCC) derived-exosomal miR-221-3p could target vasohibin-1 (VASH1) to promote lymphangiogenesis through activating the ERK/AKT pathway (Zhou et al., 2019). The gene discussed is VASH1; the disease is cervical squamous cell carcinoma.